1. Home
  2. MMSI vs AMRX Comparison

MMSI vs AMRX Comparison

Compare MMSI & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MMSI

Merit Medical Systems Inc.

HOLD

Current Price

$68.23

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$12.38

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMSI
AMRX
Founded
1987
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.0B
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
MMSI
AMRX
Price
$68.23
$12.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
4
Target Price
$103.56
$14.75
AVG Volume (30 Days)
740.9K
1.9M
Earning Date
04-23-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
4.93
157.89
EPS
2.13
0.22
Revenue
$1,515,906,000.00
N/A
Revenue This Year
$8.78
$6.40
Revenue Next Year
$5.70
$6.54
P/E Ratio
$32.03
$56.27
Revenue Growth
11.75
N/A
52 Week Low
$67.42
$6.69
52 Week High
$107.27
$15.42

Technical Indicators

Market Signals
Indicator
MMSI
AMRX
Relative Strength Index (RSI) 28.41 34.89
Support Level N/A $11.55
Resistance Level $84.91 $12.85
Average True Range (ATR) 2.31 0.50
MACD -0.39 -0.16
Stochastic Oscillator 7.26 21.61

Price Performance

Historical Comparison
MMSI
AMRX

About MMSI Merit Medical Systems Inc.

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: